Serum magnesium and mortality in hemodialysis patients in the United States: A cohort study

American Journal of Kidney Diseases

Volumn 66, Issue 6, 2015, Pages 1056-1066

  Lacson, Eduardo ^a   Wang, Weiling ^b   Ma, Lin ^a   Passlick Deetjen, Jutta ^c  

^a FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^b ALCON RESEARCH LTD   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

dialysate magnesium prescription; end stage renal disease (ESRD); hemodialysis (HD); hypermagnesemia; hypomagnesemia; mortality risk; Serum magnesium concentration

Indexed keywords

ALBUMIN; CALCIUM; HEMOGLOBIN; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; POTASSIUM; BIOLOGICAL MARKER;

AGED; ARTICLE; BODY SURFACE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; DIABETES MELLITUS; DIALYSATE LEVEL; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; HYPOMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MAGNESIUM DIALYSATE LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; SUDDEN CARDIAC DEATH; SURVIVAL; UNITED STATES; VASCULAR ACCESS; ADULT; ADVERSE EFFECTS; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TRENDS;

ADULT; AGED; BIOMARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNESIUM; MALE; MIDDLE AGED; MORTALITY; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84948094354     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.06.014     Document Type: Article

References (27)

1. E. Ishimura, S. Okuno, K. Kitatani, and et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients Clin Nephrol 68 4 2007 222 227
2. I. Tzanakis, A. Pras, D. Kounali, and et al. Mitral annular calcifications in hemodialysis patients: a possible protective role of magnesium Nephrol Dial Transplant 12 1997 2036 2037
3. I. Tzanakis, K. Virvidakis, A. Tsomi, and et al. Intra- and extracellular magnesium levels and atheromatosis in hemodialysis patients Magnes Res 17 2004 102 108
4. S. Chakraborti, T. Chakraborti, M. Mandal, A. Mandal, S. Das, and S. Ghosh Protective role of magnesium in cardiovascular diseases: a review Mol Cell Biochem 238 1-2 2002 163 179
5. E. Ishimura, S. Okuno, T. Yamakama, and et al. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients Magnes Res 20 2007 237 244
6. Y. Sakaguchi, N. Fujii, T. Shoji, and et al. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis Kidney Int 85 2014 174 181
7. P.J. Matias, A. Azevdo, I. Laranjinha, and et al. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients Blood Purif 38 2014 244 252
8. E. Lacson Jr., W. Wang, R.M. Hakim, and et al. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access Am J Kidney Dis 53 1 2009 79 90
9. M. Krishnan, H.M. Wilfehrt, and E. Lacson Jr. In data we trust: the role and utility of dialysis provider databases in the policy process Clin J Am Soc Nephrol 7 11 2012 1891 1896
10. W. Jahnen-Dechent, and M. Ketteler Magnesium basics Clin Kidney J 5 suppl 1 2012 i3 i14
11. J. Ma, A.R. Folsom, S.L. Melnick, and et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC Study J Clin Epidemiol 48 1995 927 940
12. T. Reffelmann, M. Dorr, T. Ittermann, and et al. Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors Atherosclerosis 213 2010 563 569
13. T. Reffelmann, T. Ittermann, M. Dorr, and et al. Low serum magnesium concentrations predict cardiovascular and all-cause mortality Atherosclerosis 219 2011 280 284
14. A. Markaki, J. Kyriazis, K. Stylianou, and et al. The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients PLoS One 7 12 2012 e52350
15. M.R. Joffres, D.M. Reed, and K. Yano Relationship of magnesium intake and other dietary factors to blood pressure. The Honolulu Heart Study Am J Clin Nutr 45 1987 469 475
16. J. Bazeley, B. Bieber, Y. Li, and et al. C-Reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients Clin J Am Soc Nephrol 6 2011 2452 2461
17. M.J. Blayney, R.L. Pisoni, J.L. Bragg-Gresham, and et al. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death Kidney Int 74 2008 655 663
18. D.L. Regidor, C.P. Kovesdy, R. Mehrotra, and et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients J Am Soc Nephrol 19 2008 2193 2203
19. M. Kanbay, M.I. Yilmaz, M. Apetrii, and et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients Am J Nephrol 36 2012 228 237
20. H.E. Meema, D.G. Oreopoulos, and A. Rapoport Serum magnesium level and arterial calcification in end-stage renal disease Kidney Int 32 1987 388 394
21. D.M. Spiegel, and B. Farmer Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study Hemodial Int 13 2009 453 459
22. F. Turgut, M. Kanbay, M.R. Metin, and et al. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis Int Urol Nephrol 40 2008 1075 1082
23. A.M. Khan, S.A. Lubitz, L.M. Sullivan, and et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study Circulation 127 2013 33 38
24. H. Geiger, and C. Wanner Magnesium in disease Clin Kidney J 5 suppl 1 2012 i25 i38
25. M. Mortazavi, F. Moeinzadeh, M. Saadatnia, and et al. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial Eur Neurol 69 5 2013 309 316
26. S. Salem, H. Bruck, F.H. Bahlmann, and et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification Am J Nephrol 35 2012 31 39
27. T.M. De Schutter, G.J. Behets, H. Geryl, and et al. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia Kidney Int 83 2013 1109 1117